Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
11,907,497
-
Share change
-
+1,858,337
-
Total reported value
-
$296,625,022
-
Price per share
-
$25.04
-
Number of holders
-
58
-
Value change
-
+$46,193,877
-
Number of buys
-
44
-
Number of sells
-
16
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2018
As of 30 Sep 2018,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,907,497 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., JENNISON ASSOCIATES LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, Voya Investment Management LLC, BlackRock Inc., Vanguard Group Inc, Shannon River Fund Management LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.